Medial EarlySign develops machine learning-based solutions for healthcare organizations that facilitate proactive, outcome-focused care opportunities for patients at high risk for medical conditions within a designated time frame.
Our clients and intended development partners include:
Healthcare and Provider Systems
Outcome-focused clinical insights for patient care, driven by machine learning.
EarlySign has the same objective that you do; speeding the process and more accurately providing for early detection of high-burden diseases. Utilizing our algorithm-powered suite of AlgoMarkers, healthcare organizations can successfully optimize routine clinical, EHR and lab data into actionable clinical insights.
EarlySign customizes its suite of machine-learning solutions to help you identify individuals who are at a higher risk of developing high-burden illness. With AI-powered solutions to transform the analytical review process, resources are optimized; patient outreach becomes more focused and personalized; decision-making and treatment are more efficient; and implementation is more strategic.
The Result: Potentially delaying or preventing an illness…or even saving lives.
Key features & benefits
Improved outcomes related to early detection of high burden disease
Earlier, targeted interventions can lead to lower cost of care
Point-of-care, patient–level predictive information
Personalized, patient specific insights
Solutions Validated in Research and Clinical Practice
Are you looking to solve high-burden disease challenges?
